EastWest Bioscience Inc.
HBOSF · OTC
4/30/2022 | |
|---|---|
| Revenue | $0 |
| % Growth | – |
| Cost of Goods Sold | $0 |
| Gross Profit | $0 |
| % Margin | 71.9% |
| R&D Expenses | $0 |
| G&A Expenses | $0 |
| SG&A Expenses | $0 |
| Sales & Mktg Exp. | $0 |
| Other Operating Expenses | $0 |
| Operating Expenses | $0 |
| Operating Income | -$0 |
| % Margin | -70.5% |
| Other Income/Exp. Net | -$0 |
| Pre-Tax Income | -$0 |
| Tax Expense | $0 |
| Net Income | -$0 |
| % Margin | -218.2% |
| EPS | -0.004 |
| % Growth | – |
| EPS Diluted | -0.004 |
| Weighted Avg Shares Out | 101 |
| Weighted Avg Shares Out Dil | 101 |
| Supplemental Information | – |
| Interest Income | $0 |
| Interest Expense | $0 |
| Depreciation & Amortization | $0 |
| EBITDA | -$0 |
| % Margin | -195.2% |